SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening

Despite the great success of the administered vaccines against SARS-CoV-2, the virus can still spread, as evidenced by the current circulation of the highly contagious Omicron variant. This emphasizes the additional need to develop effective antiviral countermeasures. In the context of early preclin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanhulle, Emiel, Stroobants, Joren, Provinciael, Becky, Camps, Anita, Noppen, Sam, Maes, Piet, Vermeire, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113983/
https://www.ncbi.nlm.nih.gov/pubmed/35595082
http://dx.doi.org/10.1016/j.antiviral.2022.105342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113983/
https://www.ncbi.nlm.nih.gov/pubmed/35595082
http://dx.doi.org/10.1016/j.antiviral.2022.105342

Ejemplares similares